Pizzuti Dana (CIK 1948238) reported 12 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-12-03). Recent activity: Buy CRNX (5,000 shares), Sell CRNX (5,000 shares), Buy CRNX (5,000 shares), Sell CRNX (4,900 shares), Sell CRNX (100 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-03 | Crinetics Pharmaceuticals, Inc. (CRNX) | Chief Med and Dev Officer | Buy | 5,000 | $84,450 |
| 2025-12-03 | Crinetics Pharmaceuticals, Inc. (CRNX) | Chief Med and Dev Officer | Sell | 5,000 | $225,100 |
| 2025-11-05 | Crinetics Pharmaceuticals, Inc. (CRNX) | Chief Med and Dev Officer | Buy | 5,000 | $84,450 |
| 2025-11-05 | Crinetics Pharmaceuticals, Inc. (CRNX) | Chief Med and Dev Officer | Sell | 4,900 | $208,985 |
| 2025-11-05 | Crinetics Pharmaceuticals, Inc. (CRNX) | Chief Med and Dev Officer | Sell | 100 | $4,327 |
| 2025-10-03 | Crinetics Pharmaceuticals, Inc. (CRNX) | Chief Med and Dev Officer | Buy | 5,000 | $84,450 |
| 2025-10-03 | Crinetics Pharmaceuticals, Inc. (CRNX) | Chief Med and Dev Officer | Sell | 5,000 | $209,050 |
| 2025-09-04 | Crinetics Pharmaceuticals, Inc. (CRNX) | Chief Med and Dev Officer | Buy | 5,000 | $84,450 |
| 2025-09-04 | Crinetics Pharmaceuticals, Inc. (CRNX) | Chief Med and Dev Officer | Sell | 5,000 | $160,500 |
| 2025-08-26 | Crinetics Pharmaceuticals, Inc. (CRNX) | Chief Med and Dev Officer | Buy | 30,000 | $506,700 |
| 2025-08-26 | Crinetics Pharmaceuticals, Inc. (CRNX) | Chief Med and Dev Officer | Sell | 30,000 | $912,900 |
| 2025-08-21 | Crinetics Pharmaceuticals, Inc. (CRNX) | Chief Med and Dev Officer | Sell | 6,492 | $189,437 |
来源：SEC Form 4 申报文件 · 截至 2025-12-03